von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients
- 12 July 2001
- journal article
- Published by Wiley in Haemophilia
- Vol. 7 (4), 375-380
- https://doi.org/10.1111/j.1365-2516.2001.00530.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Variable inactivation of human factor VIII from different sources by human factor VIII inhibitorsBritish Journal of Haematology, 2008
- The Half-life of Infused Factor VIII Is Shorter in Hemophiliac Patients with Blood Group 0 than in those with Blood Group AThrombosis and Haemostasis, 2000
- Effect of von Willebrand Factor and Its Proteolytic Fragments on Kinetics of Interaction between the Light and Heavy Chains of Human Factor VIIIThrombosis Research, 1999
- Factor VIII Inhibitor Antibodies with C2 Domain Specificity Are Less inhibitory to Factor VIII Complexed with von Willebrand FactorThrombosis and Haemostasis, 1996
- Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparationsHaemophilia, 1996
- Common inhibitory effects of human anti‐C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factorBritish Journal of Haematology, 1995
- Inter‐individual variation in half‐life of infused recombinant factor VIII is related to pre‐infusion von Willebrand factor antigen levelsBritish Journal of Haematology, 1995
- Epitope specificity and functional characterization of factor VIII inhibitorsPublished by Springer Nature ,1995
- Structure and function of Factor VIIIPublished by Springer Nature ,1995
- Immunoblot analysis shows changes in factor VIII inhibitor chain specificity in factor VIII inhibitor patients over timeBlood, 1988